2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

BACKGROUND: The quadrivalent meningococcal ACWY polysaccharide tetanus toxoid conjugate vaccine (MenACWY-TT; Nimenrix) is licensed in various countries to prevent disease caused by meningococcal serogroups A, C, W, and Y. In a previous study (NCT00464815), subjects aged 11‒17 years received a primar...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Quiambao, Beatriz, Peyrani, Paula, Webber, Chris, Van Der Wielen, Marie, Bianco, Veronique, Perez, John L, Cutler, Mark W, Li, Ping
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810409/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.2406
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki